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Abstract
Objective: Recovery of motor function is important for regaining indepen-
dence after stroke, but difficult to predict for individual patients. Our aim was
to develop an efficient, accurate, and accessible algorithm for use in clinical set-
tings. Clinical, neurophysiological, and neuroimaging biomarkers of corti-
cospinal integrity obtained within days of stroke were combined to predict
likely upper limb motor outcomes 3 months after stroke. Methods: Data from
207 patients recruited within 3 days of stroke [103 females (50%), median age
72 (range 18–98) years] were included in a Classification and Regression Tree
analysis to predict upper limb function 3 months poststroke. Results: The anal-
ysis produced an algorithm that sequentially combined a measure of upper limb
impairment; age; the presence or absence of upper limb motor evoked poten-
tials elicited with transcranial magnetic stimulation; and stroke lesion load
obtained from MRI or stroke severity assessed with the NIHSS score. The algo-
rithm makes correct predictions for 75% of patients. A key biomarker obtained
with transcranial magnetic stimulation is required for one third of patients.
This biomarker combined with NIHSS score can be used in place of more
costly magnetic resonance imaging, with no loss of prediction accuracy. Inter-
pretation: The new algorithm is more accurate, efficient, and accessible than its
predecessors, which may support its use in clinical practice. While further work
is needed to potentially incorporate sensory and cognitive factors, the algorithm
can be used within days of stroke to provide accurate predictions of upper limb
functional outcomes at 3 months after stroke. www.presto.auckland.ac.nz
Introduction
Recovery of upper limb motor function is important for
regaining independence after stroke.1,2 In general, greater
initial impairment is associated with worse motor out-
comes.2,3 However, experienced clinicians find it difficult
to accurately predict functional outcomes for individual
patients.4 Being able to predict motor outcomes soon
after stroke could support realistic discharge planning,
rehabilitation, goal setting, and appropriate allocation of
time and resources by clinicians and patients.5
There is growing interest in using biomarkers to predict
patients’ motor recovery and outcomes.6,7 Patients in whom
transcranial magnetic stimulation elicits a motor evoked
potential in muscles of the paretic limb typically experience
greater motor recovery and better outcomes than patients
without motor evoked potentials.3,8,9 MRI can also be used
to derive biomarkers of the motor system after stroke.10
Worse upper limb motor recovery and outcomes are pre-
dicted by greater stroke lesion load on descending cortico-
motor pathways,11 and greater asymmetry in fractional
anisotropy along the corticospinal tracts.12–15 To date no
single clinical measure or neurological biomarker has been
able to accurately predict motor recovery or outcome for all
patients, and therefore approaches using combinations of
measures and biomarkers are needed.6
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We developed the Predict Recovery Potential (PREP)
algorithm which combines clinical measures and neurologi-
cal biomarkers in the initial days after stroke to predict
upper limb functional outcomes at 3 months.15 The algo-
rithm is unique in its sequential nature, which begins with a
simple clinical test and then uses biomarkers as required to
resolve uncertainty. The algorithm has been validated in a
sample of 192 patients including those with previous stroke.5
Using PREP in clinical practice increased therapist confi-
dence, modified therapy content, and was associated with a
1 week reduction in length of stay, with no detrimental
effects on patient outcomes.5 While using PREP can increase
rehabilitation efficiency, not all clinical settings have access
to transcranial magnetic stimulation and the ability to derive
quantitative biomarkers from diffusion-weighted MRI.
The purpose of this study was to develop a new algo-
rithm that would be more efficient, accurate, and accessi-
ble to practising clinicians. We sought to determine if
TMS could be used in fewer patients than originally
proposed or even eliminated, and whether the diffusion-
weighted MRI biomarker could be replaced with a
simpler measure of stroke lesion load obtained from
T1-weighted images alone.11,16
Methods
Patients
A retrospective analysis of data from two previous studies
of 207 patients [103 females (50%); median age 72 (range
18–98) years] was carried out.5,15 Patient clinical character-
istics are summarized in Table 1. The 2014 study provided
data from 50 patients with first-ever monohemispheric
ischemic stroke. The 2017 study provided data from an
independent cohort of 157 patients with previous or first-
ever ischemic stroke or intracerebral hemorrhage. For both
studies, people were excluded if they had cerebellar stroke,
cognitive or communication impairments precluding
informed consent, or if they resided out of area precluding
follow-up. The primary outcome for both studies was
Action Research Arm Test (ARAT) score at 3 months post-
stroke (mean = 92 days, SD = 9 days), which was
obtained by a trained clinical assessor blinded to algorithm
prognosis and not involved in patient care. Upper limb
therapy dose in minutes was recorded for each session by
treating physical and occupational therapists during inpa-
tient rehabilitation, and the total number of upper limb
therapy minutes was calculated for subsequent analysis.
Algorithm measures
Shoulder abduction and finger extension strength were
graded in the paretic upper limb using the Medical
Table 1. Participant characteristics.
N = 207
Demographic characteristics
Age (years)
Median age (range) 72 (18–98)
<80 years 139 (67%)
Sex
Male 104 (50%)
Female 103 (50%)
Ethnicity
European 131 (63%)
Maori 10 (5%)
Pacific 30 (15%)
Asian 36 (17%)
Stroke risk factors
Hypertension 133 (64%)
Dyslipidemia 66 (32%)
Previous cardiac history 56 (27%)
Atrial fibrillation 47 (23%)
Diabetes mellitus 43 (21%)
Ex-smoker 35 (17%)
Smoker 17 (8%)
Stroke characteristics
First stroke
yes 181 (87%)
no 26 (13%)
Stroke type (Oxfordshire classification)
Total anterior circulation infarct 12 (6%)
Partial anterior circulation infarct 74 (36%)
Lacunar infarct 84 (40%)
Posterior circulation infarct (excluding cerebellar) 16 (8%)
Intracerebral hemorrhage 21 (10%)
Hemisphere
Right 108 (52%)
Hand
Dominant 95 (46%)
Intravenous thrombolysis
yes 19 (9%)
Endovascular thrombectomy
yes 3 (1%)
Stroke Severity
Mild (NIHSS score 0 – 4) 112 (54%)
Moderate (NIHSS score 5 – 15) 85 (41%)
Severe (NIHSS score ≥ 16) 10 (5%)
Paretic upper limb measures
Baseline SAFE score
Excellent outcome median (range) 8 (0 – 9)
Good outcome median (range) 6 (0 – 9)
Limited outcome median (range) 1 (0 – 5)
Poor outcome median (range) 0 (0 – 3)
Baseline UE-FM score
Excellent outcome median (range) 58 (16 – 65)
Good outcome median (range) 43 (6 – 63)
Limited outcome median (range) 13 (2 – 27)
Poor outcome median (range) 7 (4 – 14)
3-month UE-FM score
Excellent outcome median (range) 64 (47 – 66)
(Continued)
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Research Council (MRC) grades 3 days after stroke symp-
tom onset (median = 3 days, range = 1–4 days). The
MRC grades for each movement were summed to obtain
a SAFE score out of 10. The NIHSS and upper extremity
Fugl-Meyer (UE-FM) scores were obtained at the same
time as the SAFE score. TMS and MRI biomarkers were
obtained for all patients in the smaller cohort (n = 50),
and only as required by the PREP algorithm for patients
in the larger cohort. TMS was used to determine the pres-
ence or absence of MEPs in the paretic extensor carpi
radialis and first dorsal interosseous muscles, 5 to 7 days
poststroke. These muscles were chosen as impaired wrist
extension and index finger control often limit upper limb
function after stroke. Standard surface EMG techniques
were used, and single pulse TMS was delivered with a fig-
ure-of-eight coil connected to a MagStim 200 stimulator.
The coil was oriented to produce posterior-to-anterior
current flow in the ipsilesional primary motor cortex. The
patient was considered MEP+ if MEPs of any amplitude
were observed at a consistent latency (3 msec) on at
least 50% of at least eight trials in either of the recorded
muscles.
MRI was used 10 to 14 days poststroke to obtain three
biomarkers, described below. T1-weighted and diffusion-
weighted images were acquired with a Siemens 1.5 T
Avanto scanner. Axial T1-weighted images had
1.0 9 1.0 9 1.0 mm voxels, a 256 mm field of view,
TR = 11 msec, and TE = 4.94 msec. Diffusion-weighted
images had 1.8 9 1.8 9 3.0 mm voxels, a 230 mm field
of view, b = 2000 s.mm2, TR = 6700 msec,
TE = 101 msec, 30 gradient directions, and two averages.
The first biomarker was used in both previous studies
and involved calculating the mean fractional anisotropy
within the posterior limb of each internal capsule. A tem-
plate volume of interest for the posterior limb of each
internal capsule was warped to the patients’ images. The
microstructural characteristics of the internal capsules
were quantified by calculating an asymmetry index from
the mean fractional anisotropy values: PLIC
FAAI = (FAcontralesional – FAipsilesional)/(FAcontralesional +
FAipsilesional).
17
Two more biomarkers that could be calculated from
T1-weighted images were developed in this study. These
were stroke lesion load on the ipsilesional corticospinal
tract and sensorimotor tracts. In preparation, template
tracts were constructed using probabilistic fiber tracking
in the contralesional hemispheres of 85 patients. Diffu-
sion-weighted images were preprocessed with motion and
eddy current correction, skull stripping, estimation and
fitting of diffusion parameters, and modeling of crossing
fibers.18 Seed masks were placed at the pyramid and the
primary motor cortex (M1), with a way point at the pos-
terior limb of the internal capsule, for the corticospinal
tract template. Seed masks were placed at the medial lem-
niscus near the inferior border of the pons and the pri-
mary somatosensory cortex (S1), with a way point at the
ventral nuclei of the thalamus, for the sensory tract tem-
plate. Tractography was conducted with a curvature
threshold of 0.2 and step-length of 0.5. Tracts were then
nonlinearly transformed to MNI space and mirrored
along the mid-sagittal axis as required so that all tracts
were in the left hemisphere. Tracts from all participants
were then combined and thresholded at 75% probability
to ensure that only fibers at each tract’s core were used
for subsequent analyses. Two template tracts were gener-
ated; an M1 corticospinal tract, and a sensorimotor tract
formed by combining the S1 sensory tract with the M1
corticospinal tract. The template corticospinal and senso-
rimotor tracts were then nonlinearly registered to each
patient’s T1-weighted image. A stroke lesion mask was
hand-drawn on each patient’s T1-weighted image and the
percentage of tract voxels that overlapped the stroke
lesion was calculated.16,19
Analysis
A hypothesis-free cluster analysis of ARAT scores at
3 months poststroke was carried out, to re-evaluate the
boundaries between the four outcome categories of Excel-
lent, Good, Limited, and Poor upper limb outcome.
These category labels replace the previous labels of Com-
plete, Notable, Limited, and None.15 Each patient was
categorized into one of the four outcomes according to
their ARAT score at 3 months.
A classification and regression tree (CART) analysis
was carried out with IBM SPSS (version 24) to determine
which factors best predict outcome category. CART analy-
sis produces a decision tree without the user determining
which variables to include, or their order, in the tree. This
approach substantially differed from that used in the
development of the PREP algorithm, and means that
there were no a priori assumptions made about the likely
sequence or type of predictors that were included in the
resulting decision tree. The demographic and clinical
Table 1. Continued.
N = 207
Good outcome median (range) 54 (40 – 65)
Limited outcome median (range) 32 (21 – 50)
Poor outcome median (range) 9 (7 – 31)
Paretic upper limb measures are reported for actual (not predicted)
outcome categories, based on Action Research Arm Test score at
3 months (Table 2). NIHSS, National Institutes of Health Stroke Scale;
SAFE, Shoulder Abduction, Finger Extension; UE-FM, upper extremity
Fugl-Meyer.
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variables available to the CART analysis were sex, age
binarized at 80 years (<80, ≥80), hemisphere affected (left,
right), hand affected (dominant, nondominant), stroke
classification (lacunar infarct, partial anterior circulation
infarct, total anterior circulation infarct, posterior circula-
tion infarct, intracerebral hemorrhage), intravenous
thrombolysis (yes, no), previous stroke (yes, no), SAFE
score, stroke severity (NIHSS score), upper limb impair-
ment (UE-FM score), and upper limb therapy dose (min-
utes). The biomarkers were MEP status (MEP+, MEP),
PLIC FAAI, corticospinal tract lesion load (%), and senso-
rimotor tract lesion load (%). While therapy dose is not
known at the beginning of rehabilitation, and therefore is
not a predictor per se, it was included in the analysis as a
potential modifier of outcome.
The CART analysis had a maximum tree depth of 3,
minimum terminal node size of 10 cases, and automated
pruning to avoid over-fitting with a maximum difference
in risk of 1 standard error. “Gini” was used to optimize
homogeneity within terminal nodes. Alternative CART
analyses were carried out by removing either TMS or
MRI data, or both. The results of the CART analyses were
reformatted and combined to produce the PREP2 algo-
rithm.
Results
Cluster analysis
As in previous studies, the cluster analysis identified four
nonoverlapping outcome categories (Table 2). The cluster
boundaries were similar to those found previously15 with
the lower boundary for Good dropping from 39 to 34
points.
CART analysis
The CART analysis produced a decision tree with MEP
status as the first decision point, followed by sensorimo-
tor tract and corticospinal tract lesion load, and then
NIHSS and SAFE score, with an overall prediction accu-
racy of 73%. However, using TMS with every patient is
impractical, and unnecessary as all patients with a SAFE
score of 5 or more were MEP+ (n = 141, 68%). There-
fore, we first binarized the group according to SAFE score
(SAFE < 5, SAFE ≥ 5), and performed separate CART
analyses for each category.
For patients with a SAFE score of 5 or more, the over-
all prediction accuracy was 78% (Fig. 1, Table 3). If
patients were less than 80 years of age they were most
likely to have an Excellent upper limb outcome. If they
were 80 years old or more, and their UE-FM score was
less than 48 points, they were likely to have a Good out-
come; otherwise they were likely to have an Excellent out-
come. If UE-FM scores were removed, the CART analysis
predicted that patients aged at least 80 years were likely
to have a Good outcome if their SAFE score was 5, 6, or
7, and an Excellent outcome if their SAFE score was 8 or
more. Given that prediction accuracy was similar (79%
for UE-FM and 78% for SAFE), and the SAFE score is
quicker and easier to obtain, we elected to retain the
SAFE score in the algorithm.
For patients with a SAFE score less than 5, the overall
prediction accuracy was 70% (Fig. 2A, Table 3). Given
the smaller number of patients in this analysis (n = 66)
the minimum terminal node size was reduced from 10 to
5 cases. The CART analysis found that if patients were
MEP+ they were most likely to have a Good outcome. If
patients were MEP and had a sensorimotor tract lesion
load of 15% or less they were most likely to have a Lim-
ited outcome. If patients were MEP with a sensorimotor
tract lesion load more than 15% they had a Poor out-
come. The accuracy of predictions for MEP patients
was 90%. Note that fractional anisotropy asymmetry
indices for the posterior limbs of the internal capsules, as
well as lesion load on the corticospinal and sensorimotor
tracts, were all entered into the CART analysis. Only sen-
sorimotor tract lesion load was selected by the CART
analysis, indicating that it was a better predictor than the
other MRI biomarkers.
Alternative CART analyses were also carried out for
patients with a SAFE score less than 5. If MRI biomarkers
were removed, the CART analysis selected NIHSS score
to predict outcome for MEP patients (Fig. 2B). Patients
who were MEP were most likely to have a Limited out-
come if their NIHSS score was less than 7, and a Poor
outcome if their NIHSS score was 7 or more. The accu-
racy of predictions for MEP patients was the same as
when MRI biomarkers were available (90%). The overall
accuracy of predictions for patients with a SAFE score less
than 5 was also the same as when MRI biomarkers were
available (70%), but with different positive and negative
predictive values (Table 3).
If MEP status was removed, the CART analysis selected
NIHSS score to predict outcome for patients with a
SAFE score less than 5. Patients with an NIHSS score less
Table 2. ARAT scores for functional outcome categories 3 months
poststroke.
Outcome Mean Median Minimum Maximum N
Excellent 56 57 50 57 113
Good 43 42 34 48 55
Limited 22 22 13 31 16
Poor 2 3 0 9 23
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than 9 were most likely to have a Good outcome, while
those with an NIHSS score of 10 or more were most
likely to have a Poor outcome. However, prediction
accuracy dropped to 55% (Table 3). MRI biomarkers
were available but not selected as predictors by the CART
analysis because large overlaps in values meant they
could not be used as surrogates for MEP status. The frac-
tional anisotropy asymmetry index for the posterior
limbs of the internal capsules ranged from 0.04 to 0.53
for MEP+ patients and from 0.09 to 0.55 for MEP
patients. Corticospinal tract lesion load ranged from
0.4% to 51.1% for MEP+ patients and from 2.1% to
51.7% for MEP patients. Sensorimotor tract lesion load
ranged from 0.2% to 43.5% for MEP+ patients and from
2.0% to 39.6% for MEP patients. This indicates that
these MRI biomarkers do not distinguish between MEP+
and MEP patients.
If both TMS and MRI biomarkers were removed, the
CART analysis again used NIHSS score to predict out-
come for patients with a SAFE score less than 5. This
produced the same decision tree as when TMS was
removed.
The potential predictors that the CART analyses did
not select were sex, hemisphere affected, hand affected,
stroke classification, intravenous thrombolysis, and previ-
ous stroke. Upper limb outcome was not predicted by
these factors, nor was it modified by upper limb therapy
dose.
An algorithm for clinical use
The decision trees produced by the CART analyses were
reformatted into a new algorithm (PREP2) suitable for
use by clinicians, in order to make predictions for indi-
vidual patients (Fig. 3). The new algorithm does not
include MRI biomarkers, because the decision trees pro-
duced with and without MRI biomarker information had
equivalent prediction accuracy (Table 3), and the NIHSS
score at 3 days poststroke is more accessible than an MRI
biomarker. The information that could be offered to
patients in each predicted outcome category is provided
in Table 4.
Overall, the new algorithm correctly predicted upper
limb outcome for 156 of 207 patients (75%). Of the
remaining 51 patients, the algorithm was too optimistic
for 35 (69%) and too pessimistic for 16 (31%). See
Table 3 for positive and negative predictive values for
each outcome. Most of the patients for whom the algo-
rithm was too optimistic were predicted to have an Excel-
lent outcome, but had a Good (n = 25) or Limited
(n = 1) outcome instead. Most of the patients for whom
the algorithm was too pessimistic were predicted to have
a Good outcome, but had an Excellent outcome instead
(n = 14). This contributed to the relatively low positive
predictive value for the Good outcome category.
The new PREP2 algorithm correctly predicted the
actual (rather than minimum) level of function at
3 months for 156 of 207 patients (75%), and is more
accurate than the PREP algorithm which could predict
actual level of function for 132 of these patients (64%).
PREP2 required TMS for 66 of 207 patients (32%) in this
sample, which is more efficient than the PREP algorithm
that would have required TMS for 116 of these patients
(56%). The new PREP2 algorithm eliminated the need for
MRI for the 30 of 207 patients (15%) who were MEP,
because NIHSS score 3 days poststroke could be used
with equivalent accuracy.
Discussion
PREP2 is an efficient, accessible, and accurate algorithm
that may be useful in clinical practice. If a patient
achieves a SAFE score of 5 or more within 72 h post-
stroke, knowing their age allows prediction of a Good or
Excellent upper limb outcome. If the SAFE score is less
than 5 at 72 h poststroke, the NIHSS score can be
obtained at this time and a TMS assessment scheduled
within the next 3 days. These measures allow prediction
of a Good, Limited, or Poor outcome. While further work
is needed to potentially incorporate sensory and cognitive
factors that may affect upper limb outcomes, the PREP2
algorithm highlights the value of sequentially combining
Figure 1. CART analysis for patients with a SAFE score ≥ 5 within
72 h poststroke. All of these patients are MEP+.
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clinical predictors and a key biomarker of corticospinal
tract integrity, MEP status, for predicting upper limb
function after stroke.
This study addresses some of the limitations of previous
work. Efficiency was improved by the finding that patients
with a SAFE score of 5 or more are MEP+ so that TMS is
only required for a third of patients using PREP2, instead
of more than half if using the PREP algorithm. Accessibil-
ity was improved by removing the need for MRI scans.
Provided MEP status information is available, the NIHSS
score can be used with equivalent prediction accuracy.
Despite these simplifications, accuracy increased with
PREP2 correctly predicting the actual upper limb func-
tional outcome for 75% of patients, which is an improve-
ment on the 64% accuracy of PREP. Predictions were too
optimistic for most of the remaining 25% of patients.
Erring on the side of optimism is preferable to the alterna-
tive, to avoid reducing patient and therapist motivation.
These improvements in efficiency, accessibility, and accu-
racy may support the testing and further validation of
PREP2 in a variety of clinical settings.
The simple bedside assessment of shoulder abduction
and finger extension strength (SAFE score), combined
with the patient’s age, discriminated with 78% accuracy
between patients who had Excellent or Good upper limb
function 3 months poststroke. This 2-min assessment is
all that was needed to provide a prediction for 68% of
patients, indicating that accurate predictions can be easily
made for most patients. Age binarized at 80 years is a
new predictor identified by the CART analysis. The find-
ing that patients aged 80 years or more needed to be less
impaired (SAFE score ≥ 8) in order to achieve the same
functional outcome as their younger counterparts is in
keeping with previous reports that age is an independent
predictor of stroke outcome.2,20 TMS is only required for
patients with a SAFE score less than 5. MEP+ patients are
most likely to have Good upper limb function 3 months
poststroke. An MEP patient will have Limited or Poor
upper limb function 3 months poststroke, and NIHSS
score can be used to discriminate between these two pos-
sibilities.
The accuracy of predictions based on clinical assess-
ment alone was 78% for patients with a SAFE score of 5
or more, but only 55% for patients with a SAFE score less
than 5. Without MEP status, the CART analysis did not
select any of the MRI biomarkers employed here, and
instead selected NIHSS score to predict either a Good or
Poor outcome. However, the accuracy of these predictions
was only marginally better than chance (55%, Table 3).
The addition of TMS biomarker information increased
prediction accuracy to 70% for these patients, underlining
the value of testing corticospinal tract function in patients
with more severe motor impairment.21,22 While PREP2
requires TMS for a smaller proportion of patients, this
does not eliminate barriers to using this technique in a
clinical setting. The major barrier is the cost of the TMS
equipment but this might be offset by a reduced average
length of stay when algorithm predictions are used in
clinical practice.5 MEP status is a simple TMS measure,
which can be obtained in approximately 20 min.5 Few
patients (2%) have contraindications to TMS such as a
history of epilepsy.5 Future studies could explore the pos-
sibility of replacing TMS with SAFE scores obtained at
later time points, as per previous work.23
The positive and negative predictive values for PREP2
ranged between 83% and 99%, with the exception of the
positive predictive value for the Good category which was
only 58%. This was partly because 27% of patients pre-
dicted to have a Good outcome exceeded this expectation
and had an Excellent outcome. In clinical practice, this
Table 3. PREP2 algorithm accuracy, positive and negative predictive values.
PPV (95% CI) NPV (95% CI) Accuracy for SAFE ≥ 5 Accuracy for SAFE < 5
PREP2: Overall accuracy 75%
Excellent N = 113 79% (73–84%) 83% (75–89%) 78% 70%
Good N = 55 58% (46–68%) 84% (79–88%)
Limited N = 16 86% (44–98%) 95% (93–97%)
Poor N = 23 91% (73–98%) 99% (96–100%)
With MRI: Overall accuracy 75%
Excellent N = 113 79% (73–84%) 83% (75–89%) 78% 70%
Good N = 55 58% (46–68%) 84% (79–88%)
Limited N = 16 73% (46–89%) 100% (97–100%)
Poor N = 23 100% 92% (82–96%)
With no TMS, and no TMS or MRI: Overall accuracy 71%
Excellent N = 113 79% (73–84%) 83% (75–89%) 78% 55%
Good N = 55 53% (41–64%) 82% (77–85%)
Limited N = 16 No predictions 92%
Poor N = 23 64% (50–75%) 99% (96–100%)
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might mean that patients in this category could be
informed that they are likely to have a Good upper limb
outcome, and there is a one in four chance it could be
Excellent. Predicting that patients will achieve at least a
Good upper limb outcome increases the positive
predictive value for this category from 58% (95% CI: 46–
68%) to 85% (95% CI: 73–92%), which is similar to the
positive predictive values for the other outcome cate-
gories. For MEP patients, NIHSS score and sensorimo-
tor tract lesion load produced predictions with equivalent
accuracy (90%). However, the positive predictive value
was higher for the Limited category when NIHSS score
was used, and higher for the Poor category when sensori-
motor tract lesion load was used. In clinical practice, cer-
tainty of a Poor prognosis could be maximized using
sensorimotor tract lesion load rather than NIHSS score
for MEP patients.
Previous studies have used clinical measures alone to
predict upper limb outcomes.2–4 One study found that
patients at 48 h poststroke with a Fugl-Meyer scale score
of at least 1 point for paretic finger extension, and a
Motricity Index score of at least 9 points for shoulder
abduction, had a 98% probability of having “manual dex-
terity” 6 months poststroke, defined as an ARAT score of
at least 10 points.23 If both scores were below these cut-
offs, the probability was only 25%. Another study used
two items from the ARAT to predict whether patients
would have a Fugl-Meyer scale score of at least 32 points
at 12 months poststroke, as this was the minimum
required to perform a drinking task with the paretic
upper limb.24 Patients at 3 days poststroke whose com-
bined score on the “pour water from glass to glass” and
“place hand on top of head” items of the ARAT was at
least 2 points (out of 6) were predicted to achieve a Fugl-
Meyer score of at least 32 points by 12 months post-
stroke, with 81% accuracy.24 While the predictions made
by these studies are accurate, they are for dichotomized
outcomes that are not particularly useful. ARAT scores
between 10 and 57 points23 embrace such a wide range of
functional outcomes that making this prediction provides
very little guidance for patients or therapists. Predicting
whether a patient will be able to perform a single drink-
ing task or not, based on their expected Fugl-Meyer
score,24 is also not particularly informative when planning
rehabilitation. Neither of these predictive models has yet
been validated in independent cohorts, and the effects of
using them in clinical practice are yet to be explored.
In contrast, PREP2 predicts one of four functionally
meaningful upper limb outcomes. The sequential nature
of the algorithm means that predictions can be made for
68% of patients using only SAFE score and age, with 78%
accuracy. TMS is only needed for patients who have a
SAFE score less than 5, and is essential for identifying
which of these patients are MEP+ and have the potential
for a Good outcome. When PREP predictions are avail-
able, therapists are more confident they know what to
expect for the patient’s recovery and modify their therapy
content according to the suggested rehabilitation goals,
Figure 2. CART analyses of patients with a SAFE score < 5 at 72 h
poststroke. (A) Both TMS and MRI biomarkers available. The analysis
selects sensorimotor tract (SMT) lesion load to differentiate between
MEP patients who will have a Limited versus Poor upper limb
outcome. (B) TMS but no MRI biomarkers available. The analysis
selects NIHSS score to differentiate between MEP patients who will
have a Limited versus Poor upper limb outcome.
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and patients experience a shorter length of stay with no
detrimental effects on outcomes or satisfaction.5
One of the limitations of this study is the small num-
ber of MEP patients relative to MEP+. Further work
could usefully explore other neuroimaging biomarkers
that might provide important prognostic information for
MEP patients. These may involve measures of alterna-
tive descending motor pathways,25–28 and of the wider
ipsilesional and contralesional sensorimotor networks,
including the corpus callosum.29–33 However, more
sophisticated measures may also require expertise not
readily available in most clinical settings. Patients with
previous stroke or intracerebral hemorrhage were also rel-
atively under-represented in this study. Other possible
predictors of upper limb outcome also need to be
explored, such as impaired upper limb somatosensation,
vision, visuospatial attention, and cognition.3,34,35 It is
possible that PREP2 predictions, which are based on
motor system measures, are less likely to be achieved
when the patient’s motor performance is also affected by
deficits in sensory and cognitive domains.
PREP2 could be used for selection and stratification of
patients for upper limb rehabilitation trials initiated early
after stroke. Matching treatment and control groups on
baseline clinical measures alone runs the risk of the
groups being mismatched in terms of likely outcomes,
particularly when patients with moderate to severe initial
impairment are included. Being able to match treatment
and control groups for their expected outcome may
reduce noise and increase the trial’s sensitivity to treat-
ment effects.
PREP2 is an efficient, accessible, and accurate algorithm
that could be useful in clinical practice. Its predecessor
has been validated and found to increase rehabilitation
efficiency.5 This needs to be confirmed for PREP2, prefer-
ably in the context of a multi-site study with a larger
sample of patients being rehabilitated in a variety of clini-
cal settings.
Figure 3. The PREP2 algorithm predicts upper limb functional outcome at 3 months poststroke. The four possible upper limb outcomes are
color-coded. The colored dots depict the proportion of patients expected to achieve each color-coded outcome, depending on their pathway
through the algorithm, based on the results of the CART analysis. Patients who achieve a SAFE score of five or more within 72 h of stroke
symptom onset, and are less than 80 years old, are most likely to have an Excellent upper limb outcome. Patients who achieve a SAFE score of
five or more within 72 h of stroke symptom onset and are 80 years old or more, are most likely to have an Excellent upper limb outcome
provided their SAFE score is at least 8; otherwise they are likely to have a Good upper limb outcome. Patients whose SAFE score is less than 5 at
72 h after stroke symptom onset need TMS to determine MEP status in the paretic upper limb, a key biomarker of corticospinal tract integrity. If
a MEP can be elicited (MEP+) approximately 5 days poststroke then the patient is likely to have at least a Good upper limb outcome. If a MEP
cannot be elicited, the NIHSS score obtained 3 days poststroke can be used to predict either a Limited outcome if the score is less than 7, or a
Poor outcome if the score is 7 or more.
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